
Manufacturers are anticipating a shortage of the drug soon as some of them, including Pfizer, have already stopped producing it in India to comply with the ban order.
from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2AawuCX
via
IFTTT
0 comments:
Post a Comment